Hook / Thesis
Zoom is behaving like yesterday's software darling after a patch of negative headlines and a recent post-earnings pullback. That's an opportunity. At roughly $85 a share, the market is pricing Zoom more like a mature comms utility than an AI-enabled platform with direct exposure to one of the most valuable private AI franchises.
I recommend a measured long: enter around $86.00, stop at $74.00, and target $120.00 over the next 180 trading days. The rationale is simple - Zoom offers low-teens earnings multiples (trailing P/E ~12x), strong free cash flow (about $1.96B reported), and an equity stake in Anthropic that provides optionality beyond core conferencing revenue. Those factors create asymmetric upside if the market re-rates AI beneficiaries.
What Zoom actually does and why it matters
Zoom operates a communications and collaboration platform used across enterprise and SMB customers. Its moat is built on platform network effects: reliable real-time connectivity, integrated contact-center and phone services, and increasingly, native AI capabilities embedded into workflow. Management has been moving the product from meetings-first to an integrated collaboration platform with AI features embedded at the user and admin levels.
The market should care because this is not just about incremental feature releases. Zoom's platform reaches millions of daily users and hundreds of thousands of paid seats. AI that meaningfully improves meeting productivity, contact center outcomes, or upsell into higher-tier bundles can drive revenue per user expansion and lift retention - the same levers that justify premium multiples for SaaS franchises.
Hard numbers that back the buy case
- Market cap: roughly $25.1 billion.
- Trailing earnings per share: $7.06; P/E roughly 12x - 13x depending on exact dataset snapshot.
- Free cash flow: about $1.96 billion annually.
- Enterprise value: ~$24.23 billion; EV/EBITDA roughly 18.3x.
- 52-week range: $69.15 - $114.74; current price near $85.89 sits ~25% below the high.
Those numbers say two things. First, Zoom is a cash-generative business trading at a price consistent with a stable, profitable software company rather than a no-profit high-growth multiple. Second, the market is giving little to no premium for the company’s AI optionality and its strategic investments, including a sizeable equity stake in Anthropic that analysts have recently flagged.
Why Anthropic exposure matters
Zoom owns an equity position in Anthropic (public reporting and coverage value that stake in the low billions). News coverage in late May 2026 highlighted Zoom's exposure to Anthropic and the integration of Claude AI models into Zoom's platform. If Anthropic's valuation accelerates or its models materially improve Zoom's product economics (higher NDR, upsells, new premium features), the market can re-rate Zoom from a steady-state software multiple to a growth-optional multiple.
Valuation framing
At a ~$25.1 billion market cap and trailing EPS near $7.06, Zoom trades around 12x-13x earnings. For a company with roughly $2.0 billion in free cash flow and net cash-like balance sheet characteristics, that multiple is modest. EV/EBITDA of ~18x puts Zoom in the same neighborhood as mature software names rather than high-growth AI plays. The question for investors is whether Zoom deserves a higher multiple because of AI-driven revenue growth and strategic assets (Anthropic stake, integrations). My answer is yes - but not a blanket leap. I expect a re-rating path rather than an immediate rerate: 1) proof points on AI-driven monetization, 2) steady enterprise retention/growth, and 3) clarity on Anthropic liquidity or value realization.
Catalysts to move the stock
- Product releases and adoption metrics showing Claude or other AI model integrations driving usage and paid seat upgrades - any public metric showing higher NDR or ARPU would be material.
- Quarterly results that confirm revenue acceleration or margin expansion relative to the recent guidance that sparked the pullback.
- News around Anthropic - IPO filings or secondary transactions that mark the stake to a higher valuation would be directly accretive to shareholder value.
- Enterprise wins or contact-center customer adds that demonstrate upsell into higher-margin segments.
Trade plan (actionable)
Entry: $86.00. This is close to today's trading range and lets us participate without chasing a breakout.
Stop loss: $74.00. A break below $74 would be a technical signal that the stock is rolling into a lower trading range and would cap downside while preserving capital.
Primary target: $120.00 within a long-term (180 trading days) horizon. That target sits above the recent 52-week high and assumes a modest re-rating combined with revenue/F/CF tailwinds from AI adoption.
Time horizon: Long term (180 trading days). I expect the bulk of the move to play out over multiple quarters as AI integrations prove out and as market sentiment normalizes.
Practical notes: consider taking 30% profits at a mid-term milestone around $100 within 45 trading days if the stock rallies quickly, and re-evaluate the remainder for the full target. In the short term (10 trading days) watch headlines around earnings revisions or material partner integrations; any near-term negative catalyst may require trimming into strength.
| Trade Item | Value |
|---|---|
| Entry | $86.00 |
| Stop Loss | $74.00 |
| Target | $120.00 |
| Horizon | Long term (180 trading days) |
| Primary Rationale | AI optionality + strong free cash flow + modest valuation |
Risk profile and counterarguments
Every trade has downsides. Here are the main risks and a counterargument to the buy case:
- Execution risk on AI monetization: Embedding Claude or other models is one thing; monetizing them is another. If integrations fail to drive meaningful ARPU or NDR improvement, the re-rating won't occur.
- Competitive pressure: Big rivals with deeper enterprise footprints (Microsoft, Cisco, Google) can bundle similar AI features into adjacent products, pressuring Zoom on pricing and enterprise penetration.
- Regulatory and geo-political risk in Europe: There are active shifts toward digital sovereignty. If public-sector bans or restrictions expand (France guidance, Germany shifts), European revenue growth could weaken.
- Sentiment and technical risk: The stock is below several moving averages (50-day SMA ~$96.81) and the MACD shows bearish momentum. A technically driven sell-off could test lower support and trigger the stop.
- Anthropic stake volatility: The stake is optionality; if Anthropic's valuation disappoints or takes longer to monetize, the perceived upside evaporates.
Counterargument: The market is right to be cautious. Recent commentary and a post-earnings miss signaled weaker near-term growth, and multiples have compressed for a reason. If Zoom cannot demonstrate a clear path to incremental monetization from AI, or if competitors successfully neutralize Zoom's differentiation, the multiple could contract further and the stock may underperform.
What would change my mind
I would reduce conviction if any of the following occur:
- Quarterly results show materially weaker revenue or margin trajectories than current consensus and management provides no credible path to AI-led monetization.
- The Anthropic stake is written down materially or priced into a much lower valuation through a public transaction.
- Competitive developments that lead to meaningful enterprise customer attrition or price compression.
Conversely, conviction would rise if Zoom reports clear, repeatable metrics for AI-driven ARPU uplift, or if the Anthropic stake is marked higher via a secondary or IPO event.
Conclusion
Zoom at roughly $85 is a pragmatic long with defined risk. The company generates healthy free cash flow, trades at modest multiples, and has strategic optionality through AI integrations and an Anthropic stake. The trade is not a blind, speculative bet on AI hype; it is a structured position that pays to patient investors if Zoom can convert product integrations into monetization. Enter at $86.00 with a $74.00 stop, target $120.00 over 180 trading days, and watch for product adoption metrics and Anthropic-related news as primary re-rating triggers.
Trade idea prepared for readers looking to marry value discipline with AI upside. Monitor catalysts closely and size positions consistent with your portfolio risk tolerance.